| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.15 | 0.3 |